ezlopitant has been researched along with phorbol-12,13-diacetate in 1 studies
| Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (phorbol-12,13-diacetate) | Trials (phorbol-12,13-diacetate) | Recent Studies (post-2010) (phorbol-12,13-diacetate) |
|---|---|---|---|---|---|
| 22 | 2 | 1 | 130 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakibara, A; Tsuchiya, M; Yamamoto, M | 1 |
1 other study(ies) available for ezlopitant and phorbol-12,13-diacetate
| Article | Year |
|---|---|
A tachykinin NK1 receptor antagonist attenuates the 4 beta-phorbol-12-myristate-13-acetate-induced nociceptive behaviour in the rat.
Topics: Analgesics; Animals; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Male; Neurokinin-1 Receptor Antagonists; Pain Measurement; Phorbol Esters; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1 | 2005 |